5-Methyl-MDA

5-Methyl-MDA.svg

5-Methyl-MDA (5-Methyl-3,4-methylenedioxyamphetamine) is a psychoactive drug and a member of the amphetamine class. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known for their entactogenic and psychedelic effects.

Chemical Structure and Properties

5-Methyl-MDA is a derivative of MDA, with a methyl group attached to the fifth carbon of the benzene ring. Its chemical formula is C11H15NO2. The addition of the methyl group alters its pharmacological properties compared to its parent compound, MDA.

Pharmacology

The pharmacological profile of 5-Methyl-MDA is not as well-studied as that of MDA or MDMA. However, it is believed to act as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), similar to other compounds in the substituted amphetamines class. This means it likely increases the levels of these neurotransmitters in the brain, leading to its psychoactive effects.

Effects

The effects of 5-Methyl-MDA are reported to be similar to those of MDA and MDMA, including euphoria, increased empathy, and enhanced sensory perception. However, due to the limited research, the full spectrum of its effects and potential risks are not well understood.

Legal Status

The legal status of 5-Methyl-MDA varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to MDA and MDMA, which are often regulated under drug control laws.

Research and Use

Research on 5-Methyl-MDA is limited, and it is primarily encountered in the context of recreational drug use. Its safety profile, potential therapeutic uses, and long-term effects remain largely unknown.

See Also

• 3,4-Methylenedioxyamphetamine (MDA)
• 3,4-Methylenedioxymethamphetamine (MDMA)
• Substituted amphetamines
• Psychoactive drug
• Entactogen

‎